Literature DB >> 16518345

Familial renal glucosuria: SLC5A2 mutation analysis and evidence of salt-wasting.

J Calado1, J Loeffler, O Sakallioglu, F Gok, K Lhotta, J Barata, J Rueff.   

Abstract

Familial renal glucosuria (FRG) is an inherited renal tubular disorder characterized by persistent isolated glucosuria in the absence of hyperglycemia. Mutations in the sodium/glucose co-transporter SGLT2 coding gene, SLC5A2, were recently found to be responsible for the disorder. Here, we report the molecular and phenotype study of five unrelated FRG families. Five patients were identified and their family members screened for glucosuria. SLC5A2 coding region of index cases was polymerase chain reaction amplified and sequenced. Five different mutations are reported, including four novel alleles. The IVS12+1G>A and p.A102V alleles were identified in homozygosity in index patients of two unrelated families. A proband from another family was compound heterozygous for the p.R132H and p.A219T mutations, and the heterozygous p.Q167fsX186 frameshift allele was the only mutation detected in the affected individual from an additional pedigree. For the remaining family no mutations were detected. The patient homozygous for the p.A102V mutation had glucosuria of 65.6 g/1.73 m(2)/24 h, evidence of renal sodium wasting, mild volume depletion, and raised basal plasma renin and serum aldosterone levels. Our findings confirm previous observations that in FRG, transmitted as a codominant trait with incomplete penetrance, most mutations are private. In the only patient with massive glucosuria in our cohort there was evidence evocative of renin-angiotensin aldosterone system activation by extracellular volume depletion induced by natriuresis. Definite proof of renin-angiotensin aldosterone system activation in FGR should rely on evaluation of additional patients with massive glucosuria.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16518345     DOI: 10.1038/sj.ki.5000194

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  21 in total

Review 1.  SGLT2 inhibition in diabetes mellitus: rationale and clinical prospects.

Authors:  Ele Ferrannini; Anna Solini
Journal:  Nat Rev Endocrinol       Date:  2012-02-07       Impact factor: 43.330

2.  Familial renal glucosuria: a clinicogenetic study of 23 additional cases.

Authors:  HyunKyung Lee; Kyoung Hee Han; Hye Won Park; Jae Il Shin; Chan Jong Kim; Mee Kyung Namgung; Kee Hyuck Kim; Ja Wook Koo; Woo Young Chung; Dae-Yeol Lee; Su-Yung Kim; Hae Il Cheong
Journal:  Pediatr Nephrol       Date:  2012-07       Impact factor: 3.714

3.  The iodide-transport-defect-causing mutation R124H: a δ-amino group at position 124 is critical for maturation and trafficking of the Na+/I- symporter.

Authors:  Viktoriya Paroder; Juan P Nicola; Christopher S Ginter; Nancy Carrasco
Journal:  J Cell Sci       Date:  2013-05-20       Impact factor: 5.285

Review 4.  Renal glucose transporters: novel targets for hyperglycemia management.

Authors:  Amanda Mather; Carol Pollock
Journal:  Nat Rev Nephrol       Date:  2010-03-30       Impact factor: 28.314

Review 5.  SGLT2 inhibitors in the management of type 2 diabetes.

Authors:  R P Monica Reddy; Silvio E Inzucchi
Journal:  Endocrine       Date:  2016-06-07       Impact factor: 3.633

6.  SGLT2 mediates glucose reabsorption in the early proximal tubule.

Authors:  Volker Vallon; Kenneth A Platt; Robyn Cunard; Jana Schroth; Jean Whaley; Scott C Thomson; Hermann Koepsell; Timo Rieg
Journal:  J Am Soc Nephrol       Date:  2010-07-08       Impact factor: 10.121

7.  A novel sodium-glucose co-transporter 2 gene (SGLT2) mutation contributes to the abnormal expression of SGLT2 in renal tissues in familial renal glucosuria.

Authors:  Lei Yu; Ping Hou; Ji-Cheng Lv; Guo-Ping Liu; Hong Zhang
Journal:  Int Urol Nephrol       Date:  2014-06-08       Impact factor: 2.370

8.  Abnormal expression and dysfunction of novel SGLT2 mutations identified in familial renal glucosuria patients.

Authors:  Lei Yu; Ji-Cheng Lv; Xu-jie Zhou; Li Zhu; Ping Hou; Hong Zhang
Journal:  Hum Genet       Date:  2010-12-17       Impact factor: 4.132

9.  Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients.

Authors:  Ele Ferrannini; Elza Muscelli; Silvia Frascerra; Simona Baldi; Andrea Mari; Tim Heise; Uli C Broedl; Hans-Juergen Woerle
Journal:  J Clin Invest       Date:  2014-01-27       Impact factor: 14.808

10.  Glucosuria and all-cause mortality among general screening participants.

Authors:  Kunitoshi Iseki; Tsuneo Konta; Koichi Asahi; Kunihiro Yamagata; Shouichi Fujimoto; Kazuhiko Tsuruya; Ichiei Narita; Masato Kasahara; Yugo Shibagaki; Toshiki Moriyama; Masahide Kondo; Chiho Iseki; Tsuyoshi Watanabe
Journal:  Clin Exp Nephrol       Date:  2018-01-12       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.